Walgreens Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Walgreens Boots Alliance, Inc. WBA is expected to release earnings results for its second quarter, before the opening bell on March 28, 2024.

Analysts expect the Deerfield, Illinois-based company to report quarterly earnings at 82 cents per share, down from $1.16 per share in the year-ago period. Walgreens is projected to report quarterly revenue of $35.86 billion, according to data from Benzinga Pro.

Walgreens has reportedly taken legal action against an arbitration award of nearly $1 billion issued to telemedicine provider PWNHealth in a contract dispute.

Walgreens shares gained 2.5% to close at $21.02 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

• Morgan Stanley analyst Erin Wright maintained an Underweight rating and cut the price target from $22 to $21 on March 26, 2024. This analyst has an accuracy rate of 77%.
• RBC Capital analyst Ben Hendrix maintained a Sector Perform rating and cut the price target from $29 to $26 on Oct. 13, 2023. This analyst has an accuracy rate of 68%.
• Truist Securities analyst David Macdonald maintained a Hold rating and cut the price target from $30 to $25 on Oct. 11, 2023. This analyst has an accuracy rate of 73%.
• Mizuho analyst Ann Hynes maintained a Neutral rating and slashed the price target from $31 to $25 on Oct. 10, 2023. This analyst has an accuracy rate of 76%.
• Deutsche Bank George Hill maintained a Hold rating and lowered the price target from $34 to $27 on Sept. 22, 2023. This analyst has an accuracy rate of 60%.

Read This Next: Jim Cramer Says Don't Sell This Beauty Brand, Believes KKR And Blackstone 'Can Make More Money'